SCHEMBL4435181

SCHEMBL4435181

[CH2]CCC(=O)NC1CCCC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.69
ALDH1A1 P00352 3/20 0.62
HPGD P15428 2/20 0.60
HDAC3 O15379 2/20 0.58
HDAC1 Q13547 2/20 0.58
HDAC2 Q92769 2/20 0.58
HDAC10 Q969S8 2/20 0.58
HDAC11 Q96DB2 2/20 0.58
HDAC8 Q9BY41 2/20 0.58
HDAC6 Q9UBN7 2/20 0.58
NCOR2 Q9Y618 1/20 0.58
EPHX1 P07099 6/20 0.53
KMT2A Q03164 1/20 0.53
NPSR1 Q6W5P4 1/20 0.50
GAA P10253 1/20 0.49
LMNA P02545 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
EPHX2 P34913 2/20 0.48
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7228325 0.98 SMN1; SMN2 (0.67) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1
SCHEMBL6245526 0.91
SCHEMBL17204390 0.88 SMN1; SMN2 (0.77) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1
SCHEMBL8429090 0.86 SMN1; SMN2 (0.74) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1
SCHEMBL9701471 0.84 SMN1; SMN2 (0.78) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1
SCHEMBL10587847 0.84 ALDH1A1 (0.83) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1
SCHEMBL7553441 0.83 SMN1; SMN2 (0.75) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1
SCHEMBL4154162 0.82 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1
SCHEMBL9337868 0.80 SMN1; SMN2 (0.95) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1
SCHEMBL28668503 0.80 SMN1; SMN2 (0.95) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137187-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE Inovacia AB (SE) 2009-12-30 EP disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255153-A1 New compounds SCD, SCD5, FADS2 SMN1; SMN2 987/4885ALDH1A1 1498/4885HPGD 364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.